530 results on '"Hirankarn, Nattiya"'
Search Results
152. Frequency of HLA-DQB1*0201/02 and DQB1*0302 alleles and tissue transglutaminase antibody seropositivity in children with type 1 diabetes mellitus.
153. Urinary exosomal activating transcriptional factor 3 as the early diagnostic biomarker for sepsis-induced acute kidney injury.
154. The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients
155. Meta-analysis of GWAS on two Chinese populations followed by replication identifies novel genetic variants on the X chromosome associated with systemic lupus erythematosus
156. Types of DNA methylation status of the interspersed repetitive sequences for LINE-1, Alu, HERV-E and HERV-K in the neutrophils from systemic lupus erythematosus patients and healthy controls
157. Immunoprevalence and Immunodominance of HLA-Cw∗0801-Restricted T Cell Response Targeting the Hepatitis B Virus Envelope Transmembrane Region
158. Three SNPs in chromosome 11q23.3 are independently associated with systemic lupus erythematosus in Asians
159. DcR3 Mutations in Patients with Juvenile-onset Systemic Lupus Erythematosus Lead to Enhanced Lymphocyte Proliferation
160. DNA methylation of human endogenous retrovirus in systemic lupus erythematosus
161. Meta-analysis Followed by Replication Identifies Loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as Associated with Systemic Lupus Erythematosus in Asians
162. Genome-wide search followed by replication reveals genetic interaction of CD80 and ALOX5AP associated with systemic lupus erythematosus in Asian populations.
163. Association of interferon-gamma gene polymorphisms with susceptibility to oral lichen planus in the Thai population
164. A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis
165. APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis
166. Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions
167. A Functional Variant in MicroRNA-146a Promoter Modulates Its Expression and Confers Disease Risk for Systemic Lupus Erythematosus
168. Association of IFI200 Gene Polymorphisms with Susceptibility to Systemic Lupus Erythematosus
169. Novel genetic marker in TGFB2 gene associated with expression of TGF-β2 in leukocyte and SLE susceptibility
170. Increased interleukin-23 receptor+ T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
171. Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis
172. Association of IL-18 gene polymorphism (−137C) with arthritis manifestations in SLE: combined effect with IFN gamma gene polymorphism (+874A)
173. Meta-analysis of GWAS on two Chinese populations followed by replication identifies novel genetic variants on the X chromosome associated with systemic lupus erythematosus.
174. Interleukin-1β gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection
175. SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis
176. The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation.
177. Association of cytokine and cytokine receptor gene polymorphisms with the risk of chronic hepatitis B.
178. Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.
179. Urinary proteomics revealed prostaglandin H2D-isomerase, not Zn-α2-glycoprotein, as a biomarker for active lupus nephritis
180. Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population.
181. Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus.
182. Association of TNF-alpha, TNF-beta, IFN-gamma and IL-1Ra Gene Polymorphisms with Graves' Disease in the Thai Population.
183. Interferon Alpha mRNA level and subtypes in lesion and non-lesion from discoid lupus erythematosus patients without systemic lupus erythematosus
184. The diagnostic value of basophil activation test in patients with an immediate hypersensitivity reaction to radiocontrast media
185. Meta-analysis of genome-wide association study identifies FBN2as a novel locus associated with systemic lupus erythematosus in Thai population
186. Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody.
187. Current Paradigms of Tolerogenic Dendritic Cells and Clinical Implications for Systemic Lupus Erythematosus.
188. EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesis of Graves' ophthalmopathy.
189. Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5–11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.
190. Less Severe Sepsis in Cecal Ligation and Puncture Models with and without Lipopolysaccharide in Mice with Conditional Ezh2 -Deleted Macrophages (LysM-Cre System).
191. Immunosuppressive Polymeric Nanoparticles Targeting Dendritic Cells Alleviate Lupus Disease in Fcgr2b -/- Mice by Mediating Antigen-Specific Immune Tolerance.
192. Novel xeno-free and serum-free culturing condition to improve piggyBac transposon-based CD19 chimeric antigen receptor T-cell production and characteristics.
193. Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants.
194. The Regulatory Roles of Ezh2 in Response to Lipopolysaccharide (LPS) in Macrophages and Mice with Conditional Ezh2 Deletion with LysM-Cre System.
195. Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis.
196. An In Vitro Comparison of Costimulatory Domains in Chimeric Antigen Receptor T Cell for Breast Cancer Treatment.
197. A patient-based murine model recapitulates human STAT3 gain-of-function syndrome.
198. Highly efficient hybridoma generation and screening strategy for anti-PD-1 monoclonal antibody development.
199. A LILRB1 variant with a decreased ability to phosphorylate SHP-1 leads to autoimmune diseases.
200. MicroRNA‐mediated metabolic reprogramming of chimeric antigen receptor T cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.